|
ISRCTN
|
ISRCTN23196537
|
|
ClinicalTrials.gov identifier
|
|
|
Public title
|
A randomised placebo-controlled trial of epirubicin and quinidine in patients with advanced breast cancer
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
B29(Scot)
|
|
Study hypothesis
|
Not provided at time of registration
|
|
Ethics approval
|
Not provided at time of registration
|
|
Study design
|
Randomised placebo controlled trial
|
|
Countries of recruitment
|
United Kingdom
|
|
Disease/condition/study domain
|
Breast
|
|
Participants - inclusion criteria
|
1. Histologically proven metastatic or locally advanced disease
2. Measurable or evaluable disease
3. World Health Organisation (WHO) Performance status at least 2
4. Haemoglobin ≥10 g%
5. White Blood Count (WBC) >4.0 x10^9/l
6. Platelets ≥100 x 10^9/l
7. Bilirubin within normal range
8. Not currently receiving hormone treatment
9. No prior chemotherapy for advanced disease
|
|
Participants - exclusion criteria
|
Not provided at time of registration
|
|
Anticipated start date
|
01/01/1988
|
|
Anticipated end date
|
01/09/1992
|
|
Status of trial
|
Completed
|
|
Patient information material
|
|
|
Target number of participants
|
Not provided at time of registration
|
|
Interventions
|
Both arms receive Epirubicin 100 mg/m^2 iv every 3 weeks for a maximum of eight doses. At each cycle patients also receive a 6-day course of capsules either Quinidine 250 mg or placebo.
|
|
Primary outcome measure(s)
|
Not provided at time of registration
|
|
Secondary outcome measure(s)
|
Not provided at time of registration
|
|
Sources of funding
|
Cancer Research UK
|
|
Trial website
|
|
|
Publications
|
|
|
Contact name
|
Dr
-
-
|
|
Address
|
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
|
|
City/town
|
London
|
|
Zip/Postcode
|
NW1 2DA
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0) 20 7670 4723
|
|
Fax
|
+44 (0) 20 7670 4818
|
|
Email
|
register@ctu.mrc.ac.uk
|
|
Sponsor
|
Cancer Research UK (CRUK) (UK)
|
|
Address
|
PO Box 123
Lincoln's Inn Fields
|
|
City/town
|
London
|
|
Zip/Postcode
|
WC2A 3PX
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0)20 7317 5186
|
|
Fax
|
+44 (0)20 7487 4302
|
|
Email
|
kate.law@cancer.org.uk
|
|
Sponsor website:
|
http://www.cancer.org.uk
|
|
Date applied
|
01/07/2001
|
|
Last edited
|
19/12/2007
|
|
Date ISRCTN assigned
|
01/07/2001
|
